Saturday 17 October 2026
Export ELV’s income statement to Excel — free account
Elevance Health, Inc.
ELV Healthcare Healthcare Plans
Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024. In the quarter to June 2026, revenue grew 1.40%, EPS fell 13.1%, free cash flow fell 9.01% and total debt rose 4.08%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.
428.26
0.17
−0.04%
Follow ELV
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
12.58% | 13.25% | 12.10% | 11.17% | |
Piotroski F-Score |
5 | 6 | 6 | 6 | |
| 4.62% | 4.75% | 4.27% | 4.00% | ||
ROIC |
13.32% | 12.74% | 12.52% | 11.83% | |
Return on Tangible Assets |
20.08% | 21.25% | 19.87% | 18.00% | |
Average Days of Receivables |
41.87 | 39.49 | 41.51 | 42.45 | |
Free Cash Flow per Share |
16.87 | 14.17 | 29.34 | 28.98 | |
Free Cash Flow |
3,767.00 | 3,174.00 | 6,450.00 | 6,289.00 | |
Capital Expenditures |
(1,145.00) | (1,116.00) | (1,155.00) | (1,175.00) | |
| Other line items | |||||
Cash ROIC |
3.36% | 2.83% | 5.75% | 5.54% | |
Accounts Receivable Turnover |
9.56 | 9.81 | 8.91 | 8.65 | |
Accounts Payable Turnover |
7.38 | 7.20 | 7.01 | 6.89 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
51.29 | 52.59 | 52.83 | 53.66 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.22) | (0.16) | (0.16) | (0.16) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.11% | 0.14% | 0.12% | 0.12% | |
Interest Coverage |
6.16 | 5.79 | 5.39 | 5.08 | |
Operating CF/Net income |
0.89 | 0.76 | 1.45 | 1.50 | |
Depreciation/Fixed assets |
0.33 | 0.33 | 0.33 | 0.33 | |
Capex/Depreciation |
(0.74) | (0.72) | (0.76) | (0.78) | |
Revenue per Share |
872.46 | 888.95 | 911.81 | 926.79 | |
Operating CF per Share |
22.00 | 19.15 | 34.60 | 34.40 | |
Capex per Share |
(5.13) | (4.98) | (5.25) | (5.41) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates